Press Releases

Our latest news and press releases

Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021

Read more

Cellectis Announces Release of Abstracts at ASH Showcasing Updated Preliminary Clinical Data from BALLI-01 Study and First Preclinical Data from TALGlobin01

Read more

Cellectis to Hold Third Quarter Earnings Call on Friday, November 5, 2021 at 8AM EDT

Read more

Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021

Read more

Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting

Read more

Cellectis Announces Participation in Five Investor Conferences

Read more

Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021

Read more

Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT

Read more

Cellectis’ Innovation Days event highlighted New Product Development,  New Genome Surgery Platform .HEAL, and Manufacturing Capabilities

Read more

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021

Read more